POSC9 Early Response in the Treatment of Invasive Candida Disease, Length of Stay on the Intensive Care Unit and Projected Costs with Once-Weekly Rezafungin Antifungal Therapy
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.155
https://www.valueinhealthjournal.com/article/S1098-3015(21)01950-1/fulltext
Title :
POSC9 Early Response in the Treatment of Invasive Candida Disease, Length of Stay on the Intensive Care Unit and Projected Costs with Once-Weekly Rezafungin Antifungal Therapy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01950-1&doi=10.1016/j.jval.2021.11.155
First page :
Section Title :
Open access? :
No
Section Order :
10925